Effect of dipeptidyl peptidase‐4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus

BACKGROUND: We evaluated the effect of a dipeptidyl peptidase‐4 inhibitor (DPP‐4i) on the progression of obstructive coronary artery disease (OCAD) in patients with type 2 diabetes mellitus (T2DM) receiving insulin therapy. METHODS: Using a multicenter clinical data warehouse, we analyzed the patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Young, Ko, Seung‐Hyun, Chang, Kiyuk, Yoo, Ki Dong, Ihm, Sang‐Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Editor's Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667629/
https://www.ncbi.nlm.nih.gov/pubmed/37528628
http://dx.doi.org/10.1111/1753-0407.13449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667629/
https://www.ncbi.nlm.nih.gov/pubmed/37528628
http://dx.doi.org/10.1111/1753-0407.13449

Ejemplares similares